Detalhe da pesquisa
1.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Lancet Oncol
; 24(10): 1134-1146, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797632
2.
Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.
Cytogenet Genome Res
; 158(4): 205-212, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434093
3.
Case Report: Clinical application of immunotherapy-based combination regimen in primary osteosarcoma of the uterus.
Front Oncol
; 13: 1198765, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37469418
4.
Synchronous multiple primary malignancies of clear cell renal cell carcinoma with sarcomatoid, thyroid carcinoma: a case report.
Front Oncol
; 13: 1174306, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441417
5.
Invasive ductal carcinoma and small lymphocytic lymphoma/chronic lymphocytic leukemia manifesting as a collision breast tumor: A case report and literature review.
Open Life Sci
; 16(1): 867-871, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522780
6.
YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
Cancer Chemother Pharmacol
; 77(6): 1217-29, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27107592
7.
A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma.
Oncol Rep
; 32(6): 2564-70, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230680